DarioHealth Corp. (Dario), which provides a digital health platform for chronic condition self-management, partnered with GreenKey Health (GreenKey), which provides a value-based care management program for consumers with obstructive sleep apnea (OSA). Dario and GreenKey plan to deliver a value-based, tiered, data-driven solution for integrating behavioral health, sleep health, and cardiometabolic care through this partnership.
The joint launch of the collaboration will focus on engaging large payers as strategic channel collaborators while building a national network of aligned service providers. The strategic initiatives will utilize a mix of targeted outreach, thought leadership, and high-impact content to connect with decision-makers and advance adoption of this value-based care model.
GreenKey’s solution uses a “sleep-first” approach to OSA management. Dario’s solution uses artificial intelligence (AI) to deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Their joint solution focuses on enhanced sleep health, optimized utilization of GLP-1 medications approved by the U.S. Food and Drug Administration to treat OSA, and management for comorbid conditions. Dario and GreenKey anticipate that the solution will offer payers the following benefits:
- Reduced health care costs due to fewer emergency department visits and fewer inpatient admissions
- Increased participant productivity due to better sleep and overall health.
- Actionable data insights to continuously optimize program performance
The announcement stated that OSA affects over 29 million Americans, and that 80% of those moderate to severe cases are undiagnosed. Dario and GreenKey are marketing the solution to commercial health plans, administrative services organizations, Medicaid, and Medicare Advantage plans, as well as to self-funded employers, consultants, brokers, and value-based care providers.
Dario provides a user-centric, multi-chronic condition digital therapeutics platform focused on helping consumers make sustainable lifestyle and behavior changes. Its platform is used by health plans and other payers, self-insured employers, providers of care, and consumers.
This was reported by Dario on June 26, 2025 (accessed July 21, 2025).
Contact information: Mary Mooney, Vice President of Marketing, DarioHealth Corp., 322 W. 57th Street, # 33B, New York, NY 10019; 312-593-4280; Website: https://dariohealth.com
Contact information: Communications, GreenKey Health, LLC; Email: media@greenkeyhealth.com; Website: https://greenkey.health/
August 2025 00US25EUA0023